Literature DB >> 35919519

Do Proton-Pump Inhibitors Cause CKD and Progression of CKD?: PRO.

Linda Awdishu1, Ruben Abagyan1.   

Abstract

Entities:  

Keywords:  chronic kidney disease; chronic kidney disease progression; nephro-pharmacology; nephrotoxicity; proton-pump inhibitors

Mesh：

Substances：

Year:  2022        PMID： 35919519      PMCID： PMC9337907          DOI： 10.34067/KID.0007622021

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  13 in total

1.  THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?

Authors:  A B HILL
Journal:  Proc R Soc Med       Date:  1965-05

2.  Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  George R Bailie; Nancy A Mason; Stacey J Elder; Vittorio E Andreucci; Roger N Greenwood; Takashi Akiba; Akira Saito; Jennifer L Bragg-Gresham; Brenda W Gillespie; Eric W Young
Journal:  Hemodial Int       Date:  2006-04       Impact factor: 1.812

3.  Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.

Authors:  Benjamin Lazarus; Yuan Chen; Francis P Wilson; Yingying Sang; Alex R Chang; Josef Coresh; Morgan E Grams
Journal:  JAMA Intern Med       Date:  2016-02       Impact factor: 21.873

4.  Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases.

Authors:  Ian J Simpson; Mark R Marshall; Helen Pilmore; Paul Manley; Laurie Williams; Hla Thein; David Voss
Journal:  Nephrology (Carlton)       Date:  2006-10       Impact factor: 2.506

5.  Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.

Authors:  Yan Xie; Benjamin Bowe; Tingting Li; Hong Xian; Sumitra Balasubramanian; Ziyad Al-Aly
Journal:  J Am Soc Nephrol       Date:  2016-04-14       Impact factor: 10.121

6.  Proton pump inhibitor use and progression to major adverse renal events: a competing risk analysis.

Authors:  C H Grant; K A Gillis; J S Lees; J P Traynor; P B Mark; K I Stevens
Journal:  QJM       Date:  2019-11-01

7.  Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease.

Authors:  Yusuke Sakaguchi; Tatsuya Shoji; Terumasa Hayashi; Akira Suzuki; Morihiro Shimizu; Kensuke Mitsumoto; Hiroaki Kawabata; Kakuya Niihata; Noriyuki Okada; Yoshitaka Isaka; Hiromi Rakugi; Yoshiharu Tsubakihara
Journal:  Diabetes Care       Date:  2012-04-12       Impact factor: 19.112

Review 8.  The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.

Authors:  Chan Hyuk Park; Eun Hye Kim; Yun Ho Roh; Ha Yan Kim; Sang Kil Lee
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

9.  Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis.

Authors:  Tigran Makunts; Isaac V Cohen; Linda Awdishu; Ruben Abagyan
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

10.  Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression.

Authors:  Liza Cholin; Tarek Ashour; Ali Mehdi; Jonathan J Taliercio; Remy Daou; Susana Arrigain; Jesse D Schold; George Thomas; Joseph Nally; Nazih L Nakhoul; Georges N Nakhoul
Journal:  BMC Nephrol       Date:  2021-07-15       Impact factor: 2.585
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.